Sakowitz, Sara
Bakhtiyar, Syed Shahyan
Sanaiha, Yas
Benharash, Peyman
Yanagawa, Jane
Article History
Received: 1 October 2025
Accepted: 25 January 2026
First Online: 20 February 2026
Disclosure
: J. Yanagawa is an advisory board attendee and steering committee member for AstraZeneca, and a lung cancer workshop attendee for OncLive. P. Benharash discloses that he is a proctor for AtriCure. The other authors of this manuscript have no related conflicts of interest or disclosures to declare.
: Institutional Review Board approval: #24-5895